EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antifibrogenic Therapies in Chronic HCV Infection

I Shimizu

Current Drug Target -Infectious Disorders · 2001

DOI: 10.2174/1568005014606053 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, 2001. Verfasst von I Shimizu. Beteiligte Einrichtung: Second Department of Internal Medicine, Tokushima University School of Medicine, Tokushima, Japan. shimizui@clin.med.tokushima-u.ac.jp. Die Arbeit wurde bisher 30-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsHepatitis C, ChronicHepatocyte Growth FactorHepatocytesHumansInterferonsLiver CirrhosisOligopeptidesRetinoidsT-Lymphocytes, CytotoxicTransforming Growth Factor beta

Substanzen

AntioxidantsOligopeptidesRetinoidsTransforming Growth Factor betaHepatocyte Growth Factorarginyl-glycyl-aspartic acidInterferons

Autor:innen und Institutionen

  • Second Department of Internal Medicine, Tokushima University School of Medicine, Tokushima, Japan. shimizui@clin.med.tokushima-u.ac.jp

Zitieren

APA

Shimizu, I. (2001). Antifibrogenic Therapies in Chronic HCV Infection. Current Drug Target -Infectious Disorders. https://doi.org/10.2174/1568005014606053

Vancouver

Shimizu I. Antifibrogenic Therapies in Chronic HCV Infection. Current Drug Target -Infectious Disorders. 2001. doi:10.2174/1568005014606053

BibTeX
@article{Shimizu2001,
  author = {Shimizu, I},
  title = {Antifibrogenic Therapies in Chronic HCV Infection},
  journal = {Current Drug Target -Infectious Disorders},
  year = {2001},
  doi = {10.2174/1568005014606053}
}
Kostenlos starten →